Comments to FDA: Homeopathic Product Regulation Share page: Docket Number: FDA-2015-N-0540 These comments supplement oral remarks made at the April 20, 2015 hearing regarding the regulatory framework for homeopathic drug products. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Submits Official Comments on Section 232 National Security Investigation of Pharmaceuticals May 8, 2025 Press Releases and Statements CHPA Responds to HHS/FDA Announcement to Phase Out Petroleum-based Synthetic Dyes from America’s Food Supply Apr 22, 2025 Press Releases and Statements Health In Hand Foundation Announces Call for Nominations: 2025 U.S. Self-Care Marketing Awards Apr 22, 2025